Does FLUTAMIDE Cause Hormone-refractory prostate cancer? 6 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Hormone-refractory prostate cancer have been filed in association with FLUTAMIDE (Eulexin). This represents 2.2% of all adverse event reports for FLUTAMIDE.
6
Reports of Hormone-refractory prostate cancer with FLUTAMIDE
2.2%
of all FLUTAMIDE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Hormone-refractory prostate cancer From FLUTAMIDE?
Of the 6 reports.
Is Hormone-refractory prostate cancer Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FLUTAMIDE. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does FLUTAMIDE Cause?
Dementia alzheimer's type (96)
Prostatic specific antigen increased (23)
Anaemia (21)
Decreased appetite (17)
Prostate cancer (14)
Asthenia (13)
Product use in unapproved indication (13)
Cough (12)
Drug ineffective (12)
Death (11)
What Other Drugs Cause Hormone-refractory prostate cancer?
RADIUM RA-223 DICHLORIDE (441)
LEUPROLIDE (180)
DOCETAXEL (123)
ENZALUTAMIDE (120)
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN (110)
DAROLUTAMIDE (104)
ABIRATERONE (83)
PREDNISONE (58)
CABAZITAXEL (57)
BICALUTAMIDE (50)
Which FLUTAMIDE Alternatives Have Lower Hormone-refractory prostate cancer Risk?
FLUTAMIDE vs FLUTEMETAMOL F-18
FLUTAMIDE vs FLUTICASONE
FLUTAMIDE vs FLUTICASONE FUROATE
FLUTAMIDE vs FLUTICASONE FUROATE\SALMETEROL
FLUTAMIDE vs FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE